# Travere Therapeutics Inc. (TVTX) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $491M |
| 2024 | $233M |
| 2023 | $145M |
| 2022 | $109M |
| 2021 | $132M |
| 2020 | $198M |
| 2019 | $175M |
| 2018 | $164M |
| 2017 | $155M |
| 2016 | $134M |
| 2012 | — |
| 2011 | — |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $127M |
| 2025-09-30 | $165M |
| 2025-06-30 | $114M |
| 2025-03-31 | $82M |
| 2024-09-30 | $63M |
| 2024-06-30 | $54M |
| 2024-03-31 | $41M |
| 2023-09-30 | $37M |
| 2023-06-30 | $32M |
| 2023-03-31 | $31M |
| 2022-09-30 | $28M |
| 2022-06-30 | $54M |
| 2022-03-31 | $48M |
| 2021-09-30 | $68M |
| 2021-06-30 | $55M |
| 2021-03-31 | $47M |
| 2020-09-30 | $51M |
| 2020-06-30 | $48M |
| 2020-03-31 | $48M |
| 2019-09-30 | $44M |
| 2019-06-30 | $45M |
| 2019-03-31 | $40M |
| 2018-09-30 | $41M |
| 2018-06-30 | $41M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/TVTX/revenue)